LPTX logo

Leap Therapeutics (LPTX) Company Overview

Profile

Full Name:

Leap Therapeutics, Inc.

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

January 25, 2017

Indexes:

Not included

Description:

Leap Therapeutics (LPTX) is a biotechnology company focused on developing innovative cancer treatments. They work on new therapies that target specific cancer cells, aiming to improve patient outcomes. Their research includes both clinical trials and partnerships to advance cancer care.

Events Calendar

Earnings

Next earnings date:

Mar 18, 2025

Recent quarterly earnings:

Nov 13, 2024

Recent annual earnings:

Mar 18, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

Jun 21, 2023

Analyst ratings

Recent major analysts updates

Jan 16, 25 HC Wainwright & Co.
Buy
Nov 15, 24 HC Wainwright & Co.
Buy
Aug 13, 24 HC Wainwright & Co.
Buy
Jun 28, 24 Rodman & Renshaw
Buy
May 14, 24 HC Wainwright & Co.
Buy
Mar 19, 24 HC Wainwright & Co.
Buy
Mar 19, 24 Baird
Outperform
Nov 20, 23 Mizuho
Buy
Nov 14, 23 Raymond James
Outperform
Aug 15, 23 HC Wainwright & Co.
Buy

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for Leap Therapeutics?
  • Does Leap Therapeutics pay dividends?
  • What sector is Leap Therapeutics in?
  • What industry is Leap Therapeutics in?
  • What country is Leap Therapeutics based in?
  • When did Leap Therapeutics go public?
  • Is Leap Therapeutics in the S&P 500?
  • Is Leap Therapeutics in the NASDAQ 100?
  • Is Leap Therapeutics in the Dow Jones?
  • When was Leap Therapeutics's last earnings report?
  • When does Leap Therapeutics report earnings?
  • Should I buy Leap Therapeutics stock now?

What is the ticker symbol for Leap Therapeutics?

The ticker symbol for Leap Therapeutics is NASDAQ:LPTX

Does Leap Therapeutics pay dividends?

No, Leap Therapeutics does not pay dividends

What sector is Leap Therapeutics in?

Leap Therapeutics is in the Healthcare sector

What industry is Leap Therapeutics in?

Leap Therapeutics is in the Biotechnology industry

What country is Leap Therapeutics based in?

Leap Therapeutics is headquartered in United States

When did Leap Therapeutics go public?

Leap Therapeutics's initial public offering (IPO) was on January 25, 2017

Is Leap Therapeutics in the S&P 500?

No, Leap Therapeutics is not included in the S&P 500 index

Is Leap Therapeutics in the NASDAQ 100?

No, Leap Therapeutics is not included in the NASDAQ 100 index

Is Leap Therapeutics in the Dow Jones?

No, Leap Therapeutics is not included in the Dow Jones index

When was Leap Therapeutics's last earnings report?

Leap Therapeutics's most recent earnings report was on Nov 13, 2024

When does Leap Therapeutics report earnings?

The next expected earnings date for Leap Therapeutics is Mar 18, 2025

Should I buy Leap Therapeutics stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions